Moderna Stock News

The biotech company has set an ambitious goal for 2025.

Moderna finalized an agreement with Kenya''s government on Monday to build the U.S.-based pharmaceutical giant''s first manufacturing facility for mRNA vaccines on the African continent, Africanews reported Tuesday.

A high-profile investor delightedly piled into the stock.

A high-profile investor delightedly piled into the stock.

U.S. indices traded sharply higher Wednesday amid continued volatility on Ukraine-Russia concerns. A pullback in oil prices following the recent crude rally has helped alleviate some concerns of risin

Moderna, Inc (NASDAQ: MRNA ) and Novavax , Inc (NASDAQ: NVAX ) were trading up over 10% and 8%, respectively, at one point on Wednesday, boosted by the S&P 500’s almost 2.6% intraday gain. The pharmaceutical stocks have been heavily beaten down over the past many months, with Moderna declining over 70% from its Aug. 10, 2021 all-time high of 497.49 and Novavax plummeting about 76% from its all-time high of 331.68 printed on Feb. 9 of that same year, when the COVID-19 pandemic plagued the global community. Both Moderna and Novavax have started to flash signals the bottom may be in, because they have developed various bullish indicators on their daily charts. It should be noted, however, that events affecting the general markets, negative or positive reactions to earnings prints and news headlines can quickly invalidate patterns and breakouts. As the saying goes, "the trend is your friend until it isn''t" and any trader in a position should have a clear stop set in place and manage their …

Ritholtz Wealth Management''s Josh Brown has managed to successfully catch another falling knife — at least short term. With Moderna Inc (NASDAQ: MRNA ) 75% off its high, Brown bought shares around the $125 level. "This was on a list of tickers that I have had longstanding buy limit orders in at what I was calling ludicrous prices. Well I got my ludicrous price in Moderna yesterday," Brown said Wednesday on CNBC''s "Fast Money Halftime Report." Although Brown noted he''s not "wildly bullish" on the stock, he thinks … Full story available on Benzinga.com

Moderna Inc. (MRNA) hit session highs, rose 11%, after a CNBC commentator said he was purchasing shares of the the biotech company. CNBC commentator Josh Brown said he purchased…

To address the shortage of Covid-19 vaccines in Africa, Africa CDC says it wants to promote local vaccine production on the continent. The

Vaccine stocks popped Wednesday, but remain broadly under pressure. Their Covid wares are predicted to fall as the virus becomes endemic.

Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa. The post Moderna signs agreement for first mRNA factory in Africa appeared first on Open Access Government .

It's been more than a month since the company filed for Emergency Use Authorization of its COVID-19 vaccine.

A new chapter of a long-standing legal battle is starting.

A new chapter of a long-standing legal battle is starting.